Wichers, Marieke C <br/><br/>
Baseline immune activation as a risk factor for the onset of depression during interferon-alpha treatment.  [electronic resource] 

 -  Biological psychiatry  Jul 2006 
 - 77-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0006-3223 
<br/><br/><label>Standard No.: </label>10.1016/j.biopsych.2005.11.024  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Analysis of Variance<br/>Antiviral Agents--adverse effects<br/>Cytokines--metabolism<br/>Depressive Disorder, Major--chemically induced<br/>Female<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon-alpha--adverse effects<br/>Interleukin-10--immunology<br/>Interleukin-6--immunology<br/>Male<br/>Middle Aged<br/>Receptors, Interleukin-2--immunology<br/>Risk Factors